Clinical Trials Sponsored by Anglo Celtic Cooperative Oncology Group

Total 593 results

Anglo Celtic Cooperative Oncology Group

Completed

Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer

Breast Cancer | Infertility | Menopausal Symptoms

United Kingdom
Anglo Celtic Cooperative Oncology Group

Completed

Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast Cancer

Breast Cancer

United Kingdom
Anglo Celtic Cooperative Oncology Group
Scottish Cancer Therapy Network

Unknown

Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer

Breast Cancer | Neutropenia

United Kingdom
Dermatologic Cooperative Oncology Group

Recruiting

Multicenter Tissue Registry in Melanoma (TRIM)

Metastatic Melanoma

Germany
Hellenic Cooperative Oncology Group

Recruiting

Effects of Cytotoxic Chemotherapy and PARP Inhibition on the Genomic Contexture of Ovarian Cancer

Ovarian Cancer

Greece
Eastern Cooperative Oncology Group

Active, not recruiting

COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation

Breast Cancer, NOS

United States
Eastern Cooperative Oncology Group

Completed

Double Blind Phase III Trial of Effects of Low Dose 13-Cisretinoic Acid on Prevention of Second Primaries in Stages I-II Head and Neck Cancer

Stage I-II Head and Neck Cancer
Hellenic Cooperative Oncology Group

Active, not recruiting

Investigation of Genomic Alteration in Patients With Luminal A or Luminal B Subtypes

Breast Cancer

Greece
Hellenic Cooperative Oncology Group

Completed

Responses to COVID-19 Vaccination in Patients With Cancer (ReCOVer)

Cancer

Greece
Hellenic Cooperative Oncology Group

Completed

Prognostic Biomarkers in Patients With Urothelial Carcinoma

Bladder Cancer
Hellenic Cooperative Oncology Group

Completed

Adjuvant Chemotherapy With Epirubicin, CMF, and Weekly Docetaxel or Weekly Paclitaxel in Patients With Resected High-risk Breast Cancer

Breast Cancer | Adenocarcinoma of Breast
Hellenic Cooperative Oncology Group

Completed

Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune Disease (CIAD)

Autoimmune Diseases | Immunotherapy | Checkpoint Inhibitor

Greece
Hellenic Cooperative Oncology Group

Completed

Germline Mutations in Pancreatic Adenocarcinoma (PaMPA)

Pancreatic Cancer | Hereditary Cancer | Predisposition, Genetic | Germline Mutation Abnormality

Greece
Hellenic Cooperative Oncology Group

Completed

Pathogenic Variants in Homologous Recombination Repair Genes in Patients With Epithelial Ovarian Cancer (PaVaClO)

Epithelial Ovarian Cancer
Hellenic Cooperative Oncology Group

Completed

Real-world Data of Nivolumab in Pre-treated NSCLC

Non Small Cell Lung Cancer
Hellenic Cooperative Oncology Group

Completed

Study of Panitumumab-Capecitabine-Oxaliplatin In Wild-Type K-Ras Metastatic Colorectal Cancer Patients

Colorectal Cancer

Greece
Dermatologic Cooperative Oncology Group

Completed

Imatinib in Dermatofibrosarcoma Protuberans (DFSP)

Dermatofibrosarcoma

Germany
Dermatologic Cooperative Oncology Group

Unknown

Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon

Therapy | Adjuvant | Stage III Malignant Melanoma | Interferon Alpha

Germany
Hellenic Cooperative Oncology Group

Recruiting

Real-world Data in Patients With Breast Cancer Treated With Abemaciclib (HE11AB/21)

Breast Cancer

Greece
Hellenic Cooperative Oncology Group

Recruiting

Molecular Profiling of Colorectal Cancer

Colorectal Cancer | Colon Cancer | Colon Adenocarcinoma

Greece
Eastern Cooperative Oncology Group

Terminated

Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma

Lymphoma

United States
Hellenic Cooperative Oncology Group

Active, not recruiting

Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer

Ovarian Cancer

Greece
Hellenic Cooperative Oncology Group

Active, not recruiting

Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenocarcinoma

Breast Cancer

Greece
Hellenic Cooperative Oncology Group

Completed

Clinical Outcome and Toxicity Data in Patients With Advanced Breast Cancer Treated With CDK Inhibitors Combined With Endocrine Therapy (HeCOG/CDKi)

Breast Cancer Stage IV

Greece
Hellenic Cooperative Oncology Group

Completed

The Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients With Advanced EGFR Mutation-positive Non-small Cell Lung Cancer Treated With Afatinib

Non Small Cell Lung Cancer | EGF-R Positive Non-Small Cell Lung Cancer | EGFR Gene Mutation
Hellenic Cooperative Oncology Group

Completed

Corellation of Mutations, TILs and Age in Breast Cancer

Breast Cancer
Hellenic Cooperative Oncology Group

Completed

K-RAS and EGFR in Lung Cancer (K-RAS_NSCLC)

Non Small Cell Lung Cancer

Greece
Hellenic Cooperative Oncology Group

Completed

Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors

Breast Tumors | Brain Metastases | Lung Tumors

Greece
Hellenic Cooperative Oncology Group

Terminated

Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT) (HIT)

Metastatic Breast Cancer

Greece
Hellenic Cooperative Oncology Group

Terminated

Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC) (DOPERLO)

Advanced Non-Small Cell Lung Cancer

Greece
Hellenic Cooperative Oncology Group

Recruiting

Durvalumab in Combination With Standard Chemotherapy of Patients With Extensive Stage Small Cell Lung Cancer (DRIVE)

Small-cell Lung Cancer | Extensive-stage Small-cell Lung Cancer

Greece
Hellenic Cooperative Oncology Group

Recruiting

Osimertinib as 1st Line Therapy for Patients With Advanced EGFR Positive Non-Small Cell Lung Cancer

Lung Cancer Non-small Cell Stage IV

Greece
Eastern Cooperative Oncology Group

Recruiting

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Melanoma | Breast Cancer, NOS | CNS Primary Tumor, NOS | Cervical Cancer, NOS | Colorectal Cancer, NOS | Leukemia, NOS | Lymphoma, NOS | Miscellaneous Neoplasm, NOS | Non-Rhabdomyosarcoma Soft Tissue Sarcoma, NOS | Testicular Nonseminomatous Germ Cell Tumor, NOS | Thyroid Cancer, NOS | Bone Cancer, NOS

United States
Eastern Cooperative Oncology Group

Completed

Phase III rhu_GM-CSF + 3 Induction Regimens in Adults With Acute Non-Lymphocytic Leukemia

Adult Patients (Over 55) With Acute Non-Lymphocytic Leukemia
Hellenic Cooperative Oncology Group

Active, not recruiting

Molecular Profiling in Prostate Cancer (ProProstate)

Prostate Cancer Recurrent | Prostate Cancer Metastatic | Mutation | Germline BRCA1 Gene Mutation | Germline BRCA2 Gene Mutation

Greece
Hellenic Cooperative Oncology Group

Completed

Molecular Characterization of Gliomas Using a Broad Next Generation Sequencing (NGS)Panel

Malignant Glioma
Hellenic Cooperative Oncology Group

Active, not recruiting

Melanoma: Genomic Profiles, Molecular Markers and Therapeutic Implications

Melanoma

Greece
Hellenic Cooperative Oncology Group

Completed

Bevacizumab Versus Docetaxel/Erlotinib on Tumor Metrics in Patients With Previously Untreated Advanced Non Small Cell Lung Cancer

Non Small Cell Lung Cancer
Hellenic Cooperative Oncology Group

Terminated

Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell Carcinoma

Kidney Cancer

Greece
Hellenic Cooperative Oncology Group

Terminated

Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only Relapse

Ovarian Cancer

Greece
Dermatologic Cooperative Oncology Group

Unknown

Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma

Metastatic Melanoma

Germany
European Organisation for Research and Treatment...
Swiss Group for Clinical Cancer Research; Swedish Breast Cancer Group; Anglo...

Completed

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

Breast Cancer

France, Switzerland, Poland, Sweden, Belgium, Netherlands, United Kingdom, Portugal, Slovenia
GERCOR - Multidisciplinary Oncology Cooperative...

Not yet recruiting

First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer (BIG)

Gastric Cancer
GERCOR - Multidisciplinary Oncology Cooperative...

Recruiting

Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients (ACUPOX)

Gastric Cancer | Colorectal Cancer | Pancreas Cancer | Liver Cancer | Esophagus Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...

Recruiting

Prognostic and Predictive Markers of Treatment Response in Patients With PAC. (CANOPE)

Pancreatic Adenocarcinoma

France
GERCOR - Multidisciplinary Oncology Cooperative...

Recruiting

Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study

Biliary Tract Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...

Not yet recruiting

Effects of Combining a Neuromuscular Electrical Stimulation Intervention With Nutritional Support in Deconditioned Patients With Advanced Gastrointestinal Cancer

Cancer Digestive

France
GERCOR - Multidisciplinary Oncology Cooperative...

Active, not recruiting

LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment Efficacy (LONGBOARD)

Metastatic Colorectal Cancer

France
Latin American Cooperative Oncology Group

Active, not recruiting

Multicenter Retrospective Database on Prognostic and Predictive Factors in Patients With Neuroendocrine Tumors (LACOG/GTG 0119)

Neuroendocrine Tumors | Carcinoma;Endocrine

Brazil, Peru
GERCOR - Multidisciplinary Oncology Cooperative...

Active, not recruiting

Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer (IDEA)

Colorectal Cancer

France

Clinical Trials Sponsored by Anglo Celtic Cooperative Oncology Group

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations